trending Market Intelligence /marketintelligence/en/news-insights/trending/0lnR-2OG0KkLDVQZ-E11NA2 content esgSubNav
In This List

Rite Aid's EnvisionRx receives renewal of drug therapy program accreditation

Blog

Using ESG Analysis to Support a Sustainable Future

Video

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Q&A: Streamlining Analytics for TCFD Reporting

Blog

Evergrande and the wider impact: a sentiment analytics based perspective


Rite Aid's EnvisionRx receives renewal of drug therapy program accreditation

Rite Aid Corp.'s pharmacy benefit manager, EnvisionRx, on Dec. 11 said it received the renewal of its accreditation as a provider of a patient care program called Drug Therapy Management.

The management program aims to help patients with chronic conditions adhere to their prescribed drug therapy, thus leading to better control of the disease. The program is also designed to reduce healthcare costs.

The accreditation from URAC, a nonprofit organization that helps promote healthcare quality, is given to organizations that incorporate the program into their clinical care processes.